PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-38.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-62.05%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-71.04%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-71.04%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-69.69%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-69.70%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-69.64%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.33%
Dividend growth above 1.5x MTDR's 0.08%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-33.19%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-73.31%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
415.69%
10Y revenue/share CAGR at 50-75% of MTDR's 690.14%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
344.68%
5Y revenue/share CAGR under 50% of MTDR's 1272.50%. Michael Burry would suspect a significant competitive gap or product weakness.
161.95%
Positive 3Y CAGR while MTDR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
438.64%
10Y OCF/share CAGR under 50% of MTDR's 1566.28%. Michael Burry would worry about a persistent underperformance in cash creation.
372.62%
5Y OCF/share CAGR is similar to MTDR's 362.73%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
-21.13%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
1378.39%
Net income/share CAGR above 1.5x MTDR's 163.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
417.65%
5Y net income/share CAGR above 1.5x MTDR's 139.65%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-39.82%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
518.48%
10Y equity/share CAGR above 1.5x MTDR's 274.37%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
246.88%
5Y equity/share CAGR 1.25-1.5x MTDR's 204.54%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
89.84%
3Y equity/share CAGR at 75-90% of MTDR's 101.40%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
2016.49%
Dividend/share CAGR of 2016.49% while MTDR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
5483.84%
Dividend/share CAGR of 5483.84% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
518.27%
3Y dividend/share CAGR similar to MTDR's 529.33%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-23.94%
Firm’s AR is declining while MTDR shows 2.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-59.38%
Inventory is declining while MTDR stands at 23.07%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.43%
Negative asset growth while MTDR invests at 1.79%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.83%
We have a declining book value while MTDR shows 2.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
22.83%
Debt growth far above MTDR's 0.54%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
311.11%
We expand SG&A while MTDR cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.